Low-dose vs standard-dose alteplase for patients with acute ischemic stroke: secondary analysis of the ENCHANTED randomized clinical trial by Wang, X, Robinson, T, Lee, T, Woodward, M, al., E, ENCHANTED Investigators

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3... by Anderson, C, Huang, Y, Lindley, R, Woodward, M, for the ENCHANTED Investigators and Coordinators

The National Institute for Health Research Hyperacute Stroke Research Centres and the ENCHANTED trial: the impact of enhanced research infrastructure on trial metrics and patient o... by Thompson G. Robinson, Xia Wang, Alice C. Durham, Gary A. Ford, Joy Liao, Sine Littlewood, Christine Roffe, Philip White, John Chalmers, Craig S. Anderson, on behalf of the ENCHANTED Investigators

Get full text

Influence of renal impairment on outcome for thrombolysis-treated acute ischemic stroke: ENCHANTED post-hoc analysis by Carr, S, Wang, X, Olavarria, V, Lavados, P, Rodriguez, J, Kim, J, Lee, T, Lindley, R, Pontes-Neto, O, Ricci, S, Sato, S, Sharma, V, Woodward, M, Chalmers, J, Anderson, C, Robinson, T, ENCHANTED Investigators

Low- versus standard-dose alteplase in patients on prior antiplatelet therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study). by Robinson, T, Wang, X, Arima, H, Bath, P, Billot, L, Broderick, J, Demchuk, A, Donnan, G, Kim, J, Lavados, P, Lee, T, Lindley, R, Martins, S, Olavarria, V, Pandian, J, Parsons, M, Pontes-Neto, O, Ricci, S, Sato, S, Sharma, V, Nguyen, T, Wang, J, Woodward, M, Chalmers, J, Anderson, C, ENCHANTED Investigators